BAM
EXEL icon

Brave Asset Management’s Exelixis EXEL Stock Holding History

Brave Asset Management’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,000
Closed -$8K – 439
2014
Q3 		$8K Hold
5,000
– – 0.01% 373
2014
Q2 		$17K Buy
+5,000
New +$17.3K 0.01% 318

Other funds holding EXEL

MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Brave Asset Management's EXEL Position: Q4 2014 in Review

Brave Asset Management sold out of Exelixis (EXEL) in Q4 2014, closing a stake of 5,000 shares — an estimated $8K sold.

Brave Asset Management first reported a position in EXEL in Q2 2014 and held it in 2 quarters. The position peaked at $17K in Q2 2014. 124 funds tracked by Wall St. Rank hold EXEL as of Q4 2014.

  • Brave Asset Management reported no remaining Exelixis position as of Q4 2014 after selling out during the quarter.
  • Brave Asset Management sold 5,000 Exelixis shares in Q4 2014, an estimated $8K.
  • Brave Asset Management first reported a position in Exelixis in Q2 2014 and held it in 2 quarters.
  • Brave Asset Management's Exelixis position peaked at $17K in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Exelixis as of Q4 2014.

Based on Brave Asset Management's 13F filing for Q4 2014, filed 2 Feb 2015.